Morphosis Capital takes control of Dr. Mrini Ophthalmology Hospital and prepares a nationwide clinic network

Private equity fund Morphosis Capital is acquiring a majority stake in Dr. Mrini Ophthalmology Hospital in Constanța and is preparing to develop a national ophthalmology platform. The transaction, announced recently, is subject to customary approvals, including clearance from the Competition Council and approval for foreign direct investment.

Founded in 2011 by Dr. Hicham Mrini, the provider operates a 30-bed day hospital, an outpatient clinic, its own medical optics network and a clinic in Tulcea. The company reported turnover of more than €5 million in 2025. Dr. Mrini will remain a significant shareholder following the transaction.

This is the platform’s first investment through which Morphosis Capital aims to build Romania’s leading ophthalmology network. The strategy includes acquiring established clinics and opening new locations in major cities, offering services ranging from consultations and diagnosis to cataract surgery, refractive surgery, and treatments for retinal conditions and glaucoma.

Medical development will be coordinated by Prof. Univ. Dr. Horia T. Stanca, who will join the project as Senior Consultant. The platform is already in discussions with several clinics and will continue to treat patients both privately and through contracts with CNAS. Morphosis cites population ageing, demand for ophthalmic procedures and market fragmentation as the main opportunities for expansion.